• Je něco špatně v tomto záznamu ?

Human decellularized and crosslinked pericardium coated with bioactive molecular assemblies

J. Musilkova, E. Filova, J. Pala, R. Matejka, D. Hadraba, D. Vondrasek, O. Kaplan, T. Riedel, E. Brynda, J. Kucerova, M. Konarik, F. Lopot, . Jan Pirk, L. Bacakova,

. 2019 ; 15 (1) : 015008. [pub] 20191209

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025409

Grantová podpora
NV15-29153A MZ0 CEP - Centrální evidence projektů

Decellularized human pericardium is under study as an allogenic material for cardiovascular applications. The effects of crosslinking on the mechanical properties of decellularized pericardium were determined with a uniaxial tensile test, and the effects of crosslinking on the collagen structure of decellularized pericardium were determined by multiphoton microscopy. The viability of human umbilical vein endothelial cells seeded on decellularized human pericardium and on pericardium strongly and weakly crosslinked with glutaraldehyde and with genipin was evaluated by means of an MTS assay. The viability of the cells, measured by their metabolic activity, decreased considerably when the pericardium was crosslinked with glutaraldehyde. Conversely, the cell viability increased when the pericardium was crosslinked with genipin. Coating both non-modified pericardium and crosslinked pericardium with a fibrin mesh or with a mesh containing attached heparin and/or fibronectin led to a significant increase in cell viability. The highest degree of viability was attained for samples that were weakly crosslinked with genipin and modified by means of a fibrin and fibronectin coating. The results indicate a method by which in vivo endothelialization of human cardiac allografts or xenografts could potentially be encouraged.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025409
003      
CZ-PrNML
005      
20210214103123.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1088/1748-605X/ab52db $2 doi
035    __
$a (PubMed)31665713
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Musilkova, Jana $u Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.
245    10
$a Human decellularized and crosslinked pericardium coated with bioactive molecular assemblies / $c J. Musilkova, E. Filova, J. Pala, R. Matejka, D. Hadraba, D. Vondrasek, O. Kaplan, T. Riedel, E. Brynda, J. Kucerova, M. Konarik, F. Lopot, . Jan Pirk, L. Bacakova,
520    9_
$a Decellularized human pericardium is under study as an allogenic material for cardiovascular applications. The effects of crosslinking on the mechanical properties of decellularized pericardium were determined with a uniaxial tensile test, and the effects of crosslinking on the collagen structure of decellularized pericardium were determined by multiphoton microscopy. The viability of human umbilical vein endothelial cells seeded on decellularized human pericardium and on pericardium strongly and weakly crosslinked with glutaraldehyde and with genipin was evaluated by means of an MTS assay. The viability of the cells, measured by their metabolic activity, decreased considerably when the pericardium was crosslinked with glutaraldehyde. Conversely, the cell viability increased when the pericardium was crosslinked with genipin. Coating both non-modified pericardium and crosslinked pericardium with a fibrin mesh or with a mesh containing attached heparin and/or fibronectin led to a significant increase in cell viability. The highest degree of viability was attained for samples that were weakly crosslinked with genipin and modified by means of a fibrin and fibronectin coating. The results indicate a method by which in vivo endothelialization of human cardiac allografts or xenografts could potentially be encouraged.
650    _2
$a alografty $7 D064591
650    _2
$a zvířata $7 D000818
650    12
$a biokompatibilní materiály $x chemie $7 D001672
650    _2
$a biomechanika $7 D001696
650    _2
$a viabilita buněk $7 D002470
650    _2
$a kolagen $x chemie $x ultrastruktura $7 D003094
650    _2
$a reagencia zkříženě vázaná $7 D003432
650    _2
$a fibrin $7 D005337
650    _2
$a fibronektiny $7 D005353
650    _2
$a glutaraldehyd $7 D005976
650    _2
$a heterografty $7 D064593
650    _2
$a endoteliální buňky pupečníkové žíly (lidské) $x cytologie $x metabolismus $7 D061307
650    _2
$a lidé $7 D006801
650    _2
$a iridoidy $7 D039823
650    _2
$a testování materiálů $7 D008422
650    _2
$a mikroskopie fluorescenční multifotonová $7 D036641
650    _2
$a perikard $x chemie $x transplantace $x ultrastruktura $7 D010496
650    _2
$a povrchová plasmonová rezonance $7 D020349
650    _2
$a pevnost v tahu $7 D013718
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Filova, Elena
700    1_
$a Pala, Jan $7 xx0018653
700    1_
$a Matejka, Roman
700    1_
$a Hadraba, Daniel
700    1_
$a Vondrasek, David
700    1_
$a Kaplan, Ondrej
700    1_
$a Riedel, Tomas
700    1_
$a Brynda, Eduard
700    1_
$a Kucerova, Johanka
700    1_
$a Konarik, Miroslav
700    1_
$a Lopot, Frantisek
700    1_
$a Jan Pirk,
700    1_
$a Bacakova, Lucie
773    0_
$w MED00180190 $t Biomedical materials (Bristol, England) $x 1748-605X $g Roč. 15, č. 1 (2019), s. 015008
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31665713 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20210214103040 $b ABA008
999    __
$a ok $b bmc $g 1599554 $s 1116095
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 15 $c 1 $d 015008 $e 20191209 $i 1748-605X $m Biomedical materials $n Biomed Mater $x MED00180190
GRA    __
$a NV15-29153A $p MZ0
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...